Journal of Clinical Virology
Volume 38, Issue 1 , Pages 32-38, January 2007

Efficacy and safety of peg-IFN alfa-2a with ribavirin for the treatment of HCV/HIV coinfected patients who failed previous IFN based therapy

  • Maribel Rodríguez-Torres

      Affiliations

    • Fundación de Investigación de Diego, San Juan, Puerto Rico
    • Ponce School of Medicine, Ponce, Puerto Rico
    • Corresponding Author InformationCorresponding author at: Fundación de Investigación de Diego, Ave. De Diego 359 Suite 302, Santurce 00909, Puerto Rico. Tel.: +787 722 1248; fax: +787 721 6098.
  • ,
  • José F. Rodríguez-Orengo

      Affiliations

    • Department of Biochemistry, School of Medicine, University of Puerto Rico, San Juan, Puerto Rico
  • ,
  • Carlos F. Ríos-Bedoya

      Affiliations

    • Ponce School of Medicine, Ponce, Puerto Rico
  • ,
  • Alberto Fernández-Carbia

      Affiliations

    • University Pathologists, San Juan, Puerto Rico
  • ,
  • Elsa González-Lassalle

      Affiliations

    • Fundación de Investigación de Diego, San Juan, Puerto Rico
  • ,
  • Rosa Salgado-Mercado

      Affiliations

    • Fundación de Investigación de Diego, San Juan, Puerto Rico
  • ,
  • Acisclo M. Marxuach-Cuétara

      Affiliations

    • Fundación de Investigación de Diego, San Juan, Puerto Rico

Received 30 December 2005; received in revised form 20 June 2006; accepted 19 September 2006. published online 25 October 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1386-6532(06)00345-3

doi:10.1016/j.jcv.2006.09.009

Journal of Clinical Virology
Volume 38, Issue 1 , Pages 32-38, January 2007